Evidence map›Paper›PMID 41979679›Full record

ArticleAnnals of hematology2026

Donor selection for patients with HLA-homozygous haplotypes in allogeneic hematopoietic stem cell transplantation.

Noriyoshi Yoshinaga, Makoto Iwasaki, Koji Kato, Fumihiko Kimura, Masahiro Hirayama, Minoru Kanaya, Satoko Morishima, Naoyuki Uchida, Noriko Doki, Takahiro Fukuda and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Noriyoshi YoshinagaDepartment of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Makoto IwasakiDepartment of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Koji KatoDepartment of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Fumihiko KimuraDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
Masahiro HirayamaDepartment of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan.
Minoru KanayaBlood Disorders Center, Aiiku Hospital, Sapporo, Japan.
Satoko MorishimaCentral Japan Cord Blood Bank, Seto, Japan.
Naoyuki UchidaDepartment of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
Noriko DokiHematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Takahiro FukudaDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Yoshinobu KandaDivision of Hematology, Jichi Medical University, Tochigi, Japan.
Tetsuya NishidaDepartment of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.
Yuta HasegawaDepartment of Hematology, Hokkaido University Hospital, Sapporo, Japan.
Shinichi KakoDivision of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Masatsugu TanakaDepartment of Hematology, Kanagawa Cancer Center, Kanagawa, Japan.
Mineo KurokawaDepartment of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Noboru AsadaDepartment of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Toshiro KawakitaDepartment of Hematology, NHO Kumamoto Medical Center, Kumamoto, Japan.
Keisuke KataokaDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Yukio KondoDepartment of Hematology, Toyama Prefectural Central Hospital, Toyama, Japan.
Kazunori ImadaDepartment of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan.
Tatsuo IchinoheDepartment of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Makoto OnizukaDepartment of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan.
Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.
Junya KandaDepartment of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. jkanda16@kuhp.kyoto-u.ac.jp.

Funding

Japan Agency for Medical Research and Development JP25ck0106989Japan Agency for Medical Research and Development JP25ek0510046Japan Society for the Promotion of Science 24K11515
6 · The paper itself

Abstract

highlightsRegistry analysis of first allogeneic transplant in HLA-homozygous recipients.Overall survival did not significantly differ with related donor hetero-to-homo or cord blood hetero-to-homo transplantation.Cord blood homo-to-homo transplantation was associated with inferior survival in the primary analysis.

Indexed as

Donor SelectionHaplotypesHematopoietic Stem Cell TransplantationHLA AntigensHomozygoteAdolescentAdultChildChild, PreschoolFemaleHumansMaleMiddle AgedRegistriesTransplantation, HomologousYoung AdultHLA AntigensDonor sourceHematopoietic stem cell transplantationHLA-homozygous haplotypesHost-versus-graft direction mismatch

Identifiers

PMID41979679
PMCPMC13079546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.